Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
African Americans make up 13% of the country’s population, but only 4% of American physicians are black. This lack of racial diversity in the profession is tragic, denying this prestigious career to many worthy people and undermining the health of many African Americans, who are more likely to receive important medical services when they’re cared for by black…
Taste versus health: That’s a trade-off we are often faced with when deciding what to eat. Some foods are bad for our health but happen to taste quite good. All of us have limited willpower, and when we are exhausted those unhealthy foods become harder to resist. But did you know that when willpower is depleted,…
“What Should I Do, Doc?” – Archives of Internal Medicine
My student and colleague, Karen Scherr, recently published an excellent article showing that physicians don’t always describe robotic surgery in an unbiased manner. Here is a nice write up of that work: Author Peter Ubel referred to a study done at four Veterans Affairs medical centers of men making decisions on how best to treat…
The United States far outspends peer countries on healthcare. When American politicians complain about these high healthcare costs, they often vilify pharmaceutical and insurance companies for profiting at the expense of the general public. As I wrote earlier, such vilification is misguided, pushing too much of the blame on individual actors rather than on the…